- Home
- ANET vs MRK Comparison
ANET vs MRK Comparison
Compare ANET & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANET
- MRK
- Stock Information
- Founded
- ANET 2004
- MRK 2000
- Country
- ANET United States
- MRK United States
- Employees
- ANET N/A
- MRK N/A
- Industry
- ANET Computer Communications Equipment
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- ANET Telecommunications
- MRK Health Care
- Exchange
- ANET Nasdaq
- MRK Nasdaq
- Market Cap
- ANET 183.4B
- MRK 218.8B
- IPO Year
- ANET 2014
- MRK N/A
- Fundamental
- Price
- ANET $134.49
- MRK $86.07
- Analyst Decision
- ANET Strong Buy
- MRK Buy
- Analyst Count
- ANET 15
- MRK 15
- Target Price
- ANET $163.80
- MRK $105.29
- AVG Volume (30 Days)
- ANET 8.2M
- MRK 10.2M
- Earning Date
- ANET 11-04-2025
- MRK 10-30-2025
- Dividend Yield
- ANET N/A
- MRK 3.78%
- EPS Growth
- ANET 26.08
- MRK 58.06
- EPS
- ANET 2.63
- MRK 7.56
- Revenue
- ANET $8,448,346,000.00
- MRK $64,235,000,000.00
- Revenue This Year
- ANET $27.20
- MRK $1.82
- Revenue Next Year
- ANET $20.72
- MRK $5.10
- P/E Ratio
- ANET $50.94
- MRK $11.35
- Revenue Growth
- ANET 27.75
- MRK 1.68
- 52 Week Low
- ANET $59.43
- MRK $73.31
- 52 Week High
- ANET $164.94
- MRK $105.07
- Technical
- Relative Strength Index (RSI)
- ANET 35.70
- MRK 52.60
- Support Level
- ANET $152.33
- MRK $82.01
- Resistance Level
- ANET $164.94
- MRK $88.30
- Average True Range (ATR)
- ANET 5.74
- MRK 1.97
- MACD
- ANET -2.53
- MRK -0.25
- Stochastic Oscillator
- ANET 6.28
- MRK 59.88
About ANET Arista Networks Inc.
Arista Networks is a networking equipment provider that primarily sells Ethernet switches and software to data centers. Its marquee product is its extensible operating system, or EOS, that runs a single image across every single one of its devices. The firm operates as one reportable segment. It has steadily gained market share since its founding in 2004, with a focus on high-speed applications. Arista counts Microsoft and Meta Platforms as its largest customers and derives roughly three quarters of its sales from North America.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).